Insiders have been trading these 5 stocks: ((SNPS)), ((RDDT)), ((NTLA)), ((SYM)) and ((STX)). Here is a breakdown of their recent trades and their value.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SVP, GC & Sec Janet Lee’s recent move at Synopsys turned heads as she sold 250 shares of Synopsys stock, a transaction valued at $127,500. While the share count may seem modest, the six‑figure sale suggests a deliberate portfolio adjustment by a senior insider with deep visibility into the company’s legal and strategic roadmap. Investors often watch such $127,500 insider sales closely, weighing whether they reflect personal financial planning or a subtle signal about Synopsys’ current valuation and future trajectory.
At Reddit Inc Class A, Chief Legal Officer Benjamin Seong Lee executed a notably larger transaction, selling 6,250 shares for a total value of $1,625,000. This seven‑figure sale stands out both for its size and the seniority of the executive involved. A $1,625,000 disposal by a CLO can prompt investors to scrutinize Reddit’s evolving risk environment, regulatory landscape, and growth expectations, as they consider whether this 6,250‑share sale is a routine liquidity event or a more meaningful statement on near‑term stock performance.
Intellia Therapeutics has seen especially active insider trading, with several executives taking different positions. Director John M. Leonard sold 34,146 shares for $314,484, while Director Fred E. Cohen moved in the opposite direction, buying 150,000 shares for a substantial $1,402,500, signaling notable confidence in Intellia’s prospects. At the same time, EVP & GC James Basta sold 10,397 shares worth $95,756, EVP & CFO Edward J III Dulac sold 6,379 shares worth $58,750, and VP & CAO Michael P. Dube sold 2,989 shares for $27,528. The mix of a large $1,402,500 purchase alongside multiple sales totaling hundreds of thousands of dollars paints a complex picture of internal sentiment at Intellia Therapeutics.
In the automation space, Symbotic drew attention when CSO William M III Boyd sold 15,000 shares of Symbotic stock in a single transaction valued at $1,035,000. Such a million‑dollar‑plus insider sale can be significant for shareholders attempting to gauge how top strategy officers view the current share price. The 15,000‑share, $1,035,000 disposal may reflect profit‑taking after a strong run or a rebalancing of personal holdings, but its scale ensures that market participants will keep a close eye on future filings from Symbotic’s leadership.
At Seagate Technology, CEO William Mosley executed one of the largest insider transactions in this group, selling 19,200 shares for a hefty $5,486,311. A CEO‑level sale of $5,486,311 inevitably draws scrutiny, as investors consider how 19,200 shares leaving the chief executive’s portfolio align with Seagate’s outlook in data storage and cloud infrastructure markets. While insider sales do not automatically imply negative expectations, a transaction of this magnitude often prompts shareholders and analysts alike to reassess valuation assumptions and monitor whether additional high‑value trades follow at Seagate Tech.

